374Water Inc
NASDAQ:SCWO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
374Water Inc
Revenue
374Water Inc
Revenue Peer Comparison
374Water Inc
Glance View
374Water, Inc. is a clean technology company. The company is headquartered in Phoenix, Arizona. The firm has developed waste stream treatment systems based on Supercritical Water Oxidation (SCWO), namely the AirSCWO. The AirSCWO systems are essentially waste stream agnostic and able to treat various complex, hazardous and non-hazardous waste streams. Its SCWO is a physical-thermal process powered by water at its critical point (374°C and 221 bar) and air that yields an effective oxidation reaction that eliminates organic compounds. The firm offers AirSCWO as a modular and containerized system. The company offers a six wet tons per day throughput capacity system. Its system is used in various applications, such as residuals and biosolids, animal waste, industrial waste and sludges, food waste, spent media and landfill leachate. The firm provides services to businesses and local governments.
See Also
What is 374Water Inc's Revenue?
Revenue
215k
USD
Based on the financial report for Dec 31, 2025, 374Water Inc's Revenue amounts to 215k USD.
What is 374Water Inc's Revenue growth rate?
Revenue CAGR 10Y
-9%
Over the last year, the Revenue growth was -52%. The average annual Revenue growth rates for 374Water Inc have been -59% over the past three years , 19% over the past five years , and -9% over the past ten years .
